General

Showing 1841–1856 of 2270 results

Article: PP.03.2 Improvement of antibody-induced cell death in multiple myeloma
€3.03 Add to cart
Article: PP.04 Loss of the tumor suppressor RASSF4 is associated with aggressive disease and poor outcome in Diffuse Large B Cell Lymphoma
€3.03 Add to cart
Article: PP.05 Integrated Efficacy Results from the Phase II and Phase III Studies with Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura
€3.03 Add to cart
Article: PP.06 Capillary zone electrophoresis measured HbA2 aiding in diagnosis of underlying a-thalassemia in the presence of HbS
€3.03 Add to cart
Article: PP.07 Blood products and Hematopoietic Progenitor Cells (HPC) Hepatitis E screening: current European practices and guidelines
€3.03 Add to cart
Article: PP.08 Treatment of a patient with severe cytomegalovirus (CMV) infection after allogeneic haploidentical stem cell transplantation with donor CMV specific T cells
€3.03 Add to cart
Article: PP.09 Hemophagocytic lymphohistiocytosis induced by visceral leishmaniasis
€3.03 Add to cart
Article: PP.10 Cyclophosphamide prevents xenogeneic graft-versus-host disease, without abrogating graft-versus-leukemia effects
€3.03 Add to cart
Article: PP.11 Origin and homeostasis of regulatory T cells in chronic Graft-versus-Host Disease
€3.03 Add to cart
Article: PP.12 Analysis of differences in preventive measures after high-dose cyclophosphamide among Belgian stem cell transplant centres
€3.03 Add to cart
Article: PP.13 Improvement of antibody-induced cell death in multiple myeloma
€3.03 Add to cart
Article: PP.14 Immunophenotypic and molecular features of cuplike morphology in AML
€3.03 Add to cart
Article: PP01 CRISPR/Cas9 mediated gene correction for the Wiskott-Aldrich syndrome
€3.03 Add to cart
Article: PP01 Exploring the long non-coding RNA landscape in Juvenile Myelomonocytic Leukemia
€3.03 Add to cart
Article: PP01 Mucosal- associated invariant T cells deficiency in multiple myeloma can be overcome by PD-1 inhibition
€3.03 Add to cart
Article: PP02 Donor specific anti-HLA antibodies and allogeneic hematopoietic stem cell transplantation
€3.03 Add to cart

Article: PP.03.2 Improvement of antibody-induced cell death in multiple myeloma

Article: PP.04 Loss of the tumor suppressor RASSF4 is associated with aggressive disease and poor outcome in Diffuse Large B Cell Lymphoma

Article: PP.05 Integrated Efficacy Results from the Phase II and Phase III Studies with Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Article: PP.06 Capillary zone electrophoresis measured HbA2 aiding in diagnosis of underlying a-thalassemia in the presence of HbS

Article: PP.07 Blood products and Hematopoietic Progenitor Cells (HPC) Hepatitis E screening: current European practices and guidelines

Article: PP.08 Treatment of a patient with severe cytomegalovirus (CMV) infection after allogeneic haploidentical stem cell transplantation with donor CMV specific T cells

Article: PP.09 Hemophagocytic lymphohistiocytosis induced by visceral leishmaniasis

Article: PP.10 Cyclophosphamide prevents xenogeneic graft-versus-host disease, without abrogating graft-versus-leukemia effects

Article: PP.11 Origin and homeostasis of regulatory T cells in chronic Graft-versus-Host Disease

Article: PP.12 Analysis of differences in preventive measures after high-dose cyclophosphamide among Belgian stem cell transplant centres

Article: PP.13 Improvement of antibody-induced cell death in multiple myeloma

Article: PP.14 Immunophenotypic and molecular features of cuplike morphology in AML

Article: PP01 CRISPR/Cas9 mediated gene correction for the Wiskott-Aldrich syndrome

Article: PP01 Exploring the long non-coding RNA landscape in Juvenile Myelomonocytic Leukemia

Article: PP01 Mucosal- associated invariant T cells deficiency in multiple myeloma can be overcome by PD-1 inhibition

Article: PP02 Donor specific anti-HLA antibodies and allogeneic hematopoietic stem cell transplantation